Surgical lung biopsy for interstitial lung disease is a safe procedure in carefully selected patients.
Surgical lung biopsy for interstitial lung disease had a low serious complication rate.
Surgical lung biopsy for interstitial lung disease is a safe procedure in carefully selected patients.
Surgical lung biopsy (surgical lung biopsy) offers the highest histopathologic yield for interstitial lung disease (interstitial lung disease).
We sought to identify risk factors for complications, and developed a predictive model to help stratify risk for patients being considered for surgical lung biopsy.
Large single center retrospective study of outpatient SLBs with individually confirmed biopsy indication.
serious complications after biopsy were uncommon
172 of 231 (75 %) patients had a LOS ≤2 days.
Forced vital capacity (forced vital capacity)% was independently associated with LOS (OR of 0.98, 95 % CI 0.97-0.99).
Right ventricular systolic pressure (right ventricular systolic pressure) was also independently associated with LOS >2 days (OR 1.51, 95 % CI 1.09, 2.14).
In our experience surgical lung biopsy remains an important tool in the management of patients with interstitial lung disease.
Risk stratification suggests that patients with lower forced vital capacity% and pulmonary hypertension are at higher risk for increased LOS and a more complicated post-procedure recovery.
The odds of complications increase by 51 % with each 1 mm Hg increase in right ventricular systolic pressure as assessed by echocardiography.
Risk might be mitigated by referring patients for surgical lung biopsy earlier, rather than reserving it for when more severe disease has developed.